New Two-Drug combo aims to beat hepatitis b
NCT ID NCT06357806
First seen Mar 28, 2026 · Last updated Apr 07, 2026 · Updated 1 time
Summary
This study is testing whether adding two new drugs (Sintilimab and Peg-IFNα-2b) to a patient's existing Hepatitis B medication can help them achieve a 'functional cure.' A functional cure means the virus is undetectable and controlled without needing lifelong treatment, though this is not guaranteed for all. The trial will involve 45 adults with stable Hepatitis B to see if this combination is safe and effective at clearing the virus.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC HEPATITIS B are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
the Fifth Medical Center, Chinese PLA General Hospital
Beijing, Beijing Municipality, 100039, China
Conditions
Explore the condition pages connected to this study.